Marquette Asset Management LLC Trims Stock Holdings in UnitedHealth Group Incorporated $UNH

Marquette Asset Management LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 13.6% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 255 shares of the healthcare conglomerate’s stock after selling 40 shares during the period. Marquette Asset Management LLC’s holdings in UnitedHealth Group were worth $80,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in UNH. GAMMA Investing LLC raised its stake in shares of UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. Nuveen LLC acquired a new stake in UnitedHealth Group during the first quarter valued at approximately $3,846,764,000. Vanguard Group Inc. grew its position in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP raised its position in shares of UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock valued at $13,537,859,000 after acquiring an additional 2,486,839 shares in the last quarter. Finally, National Bank of Canada FI lifted its stake in UnitedHealth Group by 137.8% during the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock worth $859,518,000 after purchasing an additional 950,928 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have weighed in on UNH. Robert W. Baird reissued an “underperform” rating and set a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Royal Bank Of Canada decreased their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. KeyCorp cut their price target on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Sanford C. Bernstein increased their target price on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Finally, JPMorgan Chase & Co. lowered their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research report on Wednesday, August 6th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $358.95.

UnitedHealth Group Price Performance

NYSE UNH opened at $347.89 on Wednesday. The firm has a market capitalization of $315.07 billion, a PE ratio of 15.07, a P/E/G ratio of 2.23 and a beta of 0.44. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company’s 50 day simple moving average is $297.61 and its 200 day simple moving average is $362.39.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the business posted $6.80 earnings per share. The firm’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.